Barclays’s Intelligent Bio Solutions INBS Stock Holding History
Bought
Maintained
Sold
Other funds holding INBS
Barclays's INBS Position: Q3 2026 in Review
Barclays sold out of Intelligent Bio Solutions (INBS) in Q3 2026, closing a stake of 142 shares — an estimated $326 sold.
Barclays first reported a position in INBS in Q2 2026 and held it in 1 quarter. The position peaked at $326 in Q2 2026. 9 funds tracked by Wall St. Rank hold INBS as of Q3 2026.
- Barclays reported no remaining Intelligent Bio Solutions position as of Q3 2026 after selling out during the quarter.
- Barclays sold 142 Intelligent Bio Solutions shares in Q3 2026, an estimated $326.
- Barclays first reported a position in Intelligent Bio Solutions in Q2 2026 and held it in 1 quarter.
- Barclays's Intelligent Bio Solutions position peaked at $326 in Q2 2026.
- 9 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.